BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 28, 2004
View Archived Issues
Bayer presents new Raf kinase inhibitors with potential utility in cancer therapy
Read More
Novel tachykinin NK1 antagonists designed at Merck
Read More
New NY-ESO-1-derived peptide and its use reported in a recent patent
Read More
Santhera claims new calpain inhibitors for muscular dystrophy and other uses
Read More
New ALK5 inhibitors covered by Pfizer patent
Read More
Novel TNF-alpha and IL-1 production inhibitors discovered at Pliva
Read More
Vertex describes Na+ and/or Ca2+ channel blockers for pain and other uses
Read More
Small molecule by Avidex blocks release of proinflammatory cytokines
Read More
Dual action analgesic with high safety profile
Read More
Stalevo study to investigate delaying of motor complications in Parkinson's
Read More
SomatoKine designated orphan drug in Europe for extreme insulin resistance
Read More
Peregrine discusses Tarvacin IND with FDA
Read More
Prasugrel to be studied in PCI patients in phase III trial
Read More
Protox signs license agreement for genetically modified Aerolysin protein
Read More
Arimoclomol demonstrates potential for type 2 diabetes
Read More
Exelixis initiates phase I trial for XL-999
Read More
IND filing for phase II lung cancer study of NX-473
Read More
Innodia begins phase I trial in Canada for ID-1101
Read More
Promising phase II results reported for BAY-43-9006 in advanced kidney cancer
Read More
Ralfinamide found effective in the management of neuropathic pain
Read More
HCT-3012 reported to reduce systolic blood pressure in patients with osteoarthritis
Read More
Zometa receives Japanese approval
Read More
Potential therapeutic effects of strontium ranelate in osteoarthritis
Read More
New phase I/II study for CYT007-TNFQb for psoriasis
Read More
European approval for Emselex
Read More
Dapoxetine improves latency time in patients with premature ejaculation
Read More
Uridine shows anxiolytic-like effects in rodent models of anxiety
Read More
ACAT inhibitor K-10191 shows promise as a plaque-stabilizing antiatherosclerotic agent
Read More
Effect of donepezil on cognitive function in MS unclear
Read More
Phase I/II trial supports activity of epratuzumab in non-Hodgkin's lymphoma
Read More
A 14-year study supports Lp-PLA2 as novel risk factor for CHD / News in Context
Read More
Chemokine CCR5 inhibitor provides potent protection from vaginal SHIV transmission
Read More